Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
37.31
-0.08 (-0.21%)
At close: Sep 17, 2025, 4:00 PM EDT
37.29
-0.02 (-0.05%)
Pre-market: Sep 18, 2025, 4:00 AM EDT
Smith & Nephew Employees
Smith & Nephew had 18,060 employees as of December 31, 2024. The number of employees decreased by 1,021 or -5.35% compared to the previous year.
Employees
18,060
Change (1Y)
-1,021
Growth (1Y)
-5.35%
Revenue / Employee
$329,125
Profits / Employee
$27,187
Market Cap
16.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18,060 | -1,021 | -5.35% |
Dec 31, 2023 | 19,081 | -13 | -0.07% |
Dec 31, 2022 | 19,094 | 118 | 0.62% |
Dec 31, 2021 | 18,976 | 395 | 2.13% |
Dec 31, 2020 | 18,581 | 551 | 3.06% |
Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
Dec 31, 2018 | 16,681 | 348 | 2.13% |
Dec 31, 2017 | 16,333 | 749 | 4.81% |
Dec 31, 2016 | 15,584 | 898 | 6.11% |
Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
Dec 31, 2013 | 11,036 | 559 | 5.34% |
Dec 31, 2012 | 10,477 | -266 | -2.48% |
Dec 31, 2011 | 10,743 | 571 | 5.61% |
Dec 31, 2010 | 10,172 | 408 | 4.18% |
Dec 31, 2009 | 9,764 | 7 | 0.07% |
Dec 31, 2008 | 9,757 | 567 | 6.17% |
Dec 31, 2007 | 9,190 | 360 | 4.08% |
Dec 31, 2006 | 8,830 | 212 | 2.46% |
Dec 31, 2005 | 8,618 | 752 | 9.56% |
Dec 31, 2004 | 7,866 | 415 | 5.57% |
Feb 16, 2003 | 7,451 | -55 | -0.73% |
Dec 31, 2002 | 7,506 | -420 | -5.30% |
Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
Dec 31, 2000 | 10,435 | -778 | -6.94% |
Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SNN News
- 6 days ago - Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant - GlobeNewsWire
- 14 days ago - Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System - GlobeNewsWire
- 5 weeks ago - Smith & Nephew: Doing Better And Still Offers Value - Seeking Alpha
- 6 weeks ago - Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Top 2 Health Care Stocks You May Want To Dump In Q3 - Benzinga
- 2 months ago - Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option - GlobeNewsWire
- 3 months ago - Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures - GlobeNewsWire
- 3 months ago - Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer - GlobeNewsWire